Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers

<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...

Descripció completa

Dades bibliogràfiques
Autors principals:	Ahmed, T, Tina Ahmed
Altres autors:	Hanke, T
Format:	Thesis
Idioma:	English
Publicat:	2014
Matèries:	Medical Sciences Vaccinology Immunology Infectious diseases HIV/AIDS

Ítems similars

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
per: Wan, L, et al.
Publicat: (2012)

Architecture of the HIV-1 glycan shield
per: Pritchard, L
Publicat: (2014)

HIV-specific interleukin-10 responses and immune modulation
per: Clutton, G
Publicat: (2012)

Antibody-based HIV-1 vaccines: recent developments and future directions
per: Montefiori, D, et al.
Publicat: (2007)

T-cell receptor (TCR) usage in HIV-2 infection
per: Moysi, E
Publicat: (2012)

Characterisation of the HIV-1 reservoir and the potential for viral eradication
per: Williams, J, et al.
Publicat: (2014)

T cell responses in Kenyan infants: impact on HIV-1 evolution during infection and an assessment of vaccine-induced memory responses in HIV-exposed uninfected infants
per: Garcia Knight, M
Publicat: (2014)

Identification of immunological targets for HIV-1 vaccine and cure strategies
per: Hancock, G
Publicat: (2014)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
per: Antrobus, R
Publicat: (2014)

Immunodominant CD8+ T cell responses to HIV-1 infection - 'The good and the bad'
per: Culshaw, A
Publicat: (2011)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
per: Warrell, M, et al.
Publicat: (2008)

Natural and therapy-induced immune control of HIV-1
per: Yager, N
Publicat: (2011)

A study of the phenotype and function of HLA-C restricted CD8 T cells in HIV-1 infection
per: Corrah, TW
Publicat: (2011)

Imaging of HIV-1 spread from T cells and Macrophages to Astrocytes
per: Do, T
Publicat: (2014)

The impact of host and therapy mediated selection on HIV-1 evolution
per: Huang, K
Publicat: (2010)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
per: Harris, S, et al.
Publicat: (2013)

B cell responses to conjugate and polysaccharide meningococcal vaccines
per: Ramasamy, M
Publicat: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
per: Bauza, K
Publicat: (2012)

The impact of HIV-1 disease and its treatment on mycobacterium tuberculosis-specific immunity
per: Murray, L
Publicat: (2014)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
per: Alharbi, N
Publicat: (2014)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
per: Elias, SC
Publicat: (2014)

HLA-B51 associated HIV-1 viral control
per: Peng, Y
Publicat: (2013)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
per: Wang, LT
Publicat: (2022)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
per: Hennig, B, et al.
Publicat: (2008)

Towards a universally effective HLA-E-targeted HIV vaccine - a structural and biophysical exploration
per: Walters, L
Publicat: (2019)

Definition of the early HIV-1 signalosome in dendritic cells
per: Khatamzas, E
Publicat: (2013)

Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
per: Julie L. Mitchell, et al.
Publicat: (2022-01-01)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
per: Ronan, E
Publicat: (2011)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
per: Pinpathomrat, N
Publicat: (2018)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
per: de Cassan, S
Publicat: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
per: Griffiths, K
Publicat: (2012)

Assessment of HIV-1 integration in tissues and subsets across infection stages
per: Vincent H. Wu, et al.
Publicat: (2020-12-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
per: Ochiai, R
Publicat: (2011)

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
per: Rachel L. Rutishauser, et al.
Publicat: (2021-02-01)

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
per: Gabriel Duette, et al.
Publicat: (2022-04-01)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
per: Matsumiya, M, et al.
Publicat: (2014)

Innate immune responses to tuberculosis vaccines
per: Matsumiya, M
Publicat: (2014)

Biodegradable pulsatile release technologies for viral vector based vaccinations
per: Krastev, C
Publicat: (2018)

IL-15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells
per: Yuhao Li, et al.
Publicat: (2023-04-01)

Population-specific HLA impact in immune control of HIV in Mexico and non-Mexican HIV infected cohorts
per: Juarez Molina, CI
Publicat: (2014)